Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Sep 24:9:49-54.
doi: 10.1016/j.ijregi.2023.09.005. eCollection 2023 Dec.

Exploring the relationship between anellovirus load and clinical variables in hospitalized COVID-19 patients: Implications for immune activation and inflammation

Marijn Thijssen  1 , Timothy Devos  2 , Geert Meyfroidt  3 , Marc Van Ranst  1 , Mahmoud Reza Pourkarim  1   4   5
Affiliations

Exploring the relationship between anellovirus load and clinical variables in hospitalized COVID-19 patients: Implications for immune activation and inflammation

Marijn Thijssen et al. IJID Reg. .

Abstract

Objectives: Anelloviruses have been linked with host-immunocompetence and inflammation. Here, we studied the anellovirus load in hospitalized COVID-19 patients.

Methods: We collected samples of patients recruited in the DAWN-Plasma trial that received convalescent plasma (CP) therapy (four plasma units) combined with standard of care (SOC) or SOC of alone. Plasma samples were collected on day 0 and 6 of hospitalization and we quantified anellovirus load. With multivariate models, clinical variables were associated with changes in anellovirus load.

Results: Samples were collected on day 0 and 6 of 150 patients (103 CP + SOC and 47 SOC). Anellovirus load was higher on day 0 compared to day 6 and we found a significant drop in SOC patients. Patients receiving immunosuppressive drug had a lower anellovirus load (coefficient: 1.021, 95% confidence interval [CI] 0.270-1.772, P = 0.008), while patients admitted to the emergency room displayed a higher abundance on day 0 (1.308, 95% CI 0.443-2.173, P = 0.003). Unspecific markers of inflammation and organ damage, D-dimer (0.001, 95% CI <0.001-0.001, P = 0.001) and lactate dehydrogenase (0.002, 95% CI 0.001-0.004, P = 0.044), were positively associated with anellovirus load. Finally, anellovirus load on day 0 (-39.9, 95% CI -75.72 to -4.27, P = 0.029) was negatively associated with SARS-CoV-2 antibody response on day.

Conclusion: The results showed associations between clinical variables and anellovirus load in COVID-19 patients. Many variables share properties related to host immunocompetence or inflammation. Therefore, we expect that anellovirus abundance displays the net state of immune activation.

Keywords: Anellovirus; Blood; COVID-19; Convalescent plasma therapy; SARS-CoV-2.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.

Figures

Image, graphical abstract
Graphical abstract
Figure 1
Figure 1
Anellovirus dynamics in hospitalized COVID-19 patients. (a) Change in anellovirus load (copies/ml) from inclusion (day 0) to day 6 of hospitalization. (b) Change in anellovirus load (copies/ml) between day 0 and day 6 grouped according to treatment group. SOC: standard of care; Plasma: convalescent plasma therapy. * P <0.05, ** P <0.01, paired Wilcoxon rank sum test. Green lines: increase, red lines: decrease and blue lines: equal. Boxplots show the median and interquartile ranges.
See this image and copyright information in PMC

References

    1. Thijssen M, Khamisipour G, Maleki M, Devos T, Li G, Van Ranst M, et al. Characterization of the human blood virome in Iranian multiple transfused patients. Viruses. 2023;15:1425. doi: 10.3390/v15071425. - DOI - PMC - PubMed
    1. Thijssen M, Tacke F, Van Espen L, Cassiman D, Naser Aldine MN, Nevens F, et al. Plasma virome dynamics in chronic hepatitis B virus infected patients. Front Microbiol. 2023;14 doi: 10.3389/fmicb.2023.1172574. - DOI - PMC - PubMed
    1. Thijssen M, Tacke F, Beller L, Deboutte W, Yinda KC, Nevens F, et al. Clinical relevance of plasma virome dynamics in liver transplant recipients. EBioMedicine. 2020;60 - PMC - PubMed
    1. De Vlaminck I, Khush KK, Strehl C, Kohli B, Luikart H, Neff NF, et al. Temporal response of the human virome to immunosuppression and antiviral therapy. Cell. 2013;155:1178–1187. doi: 10.1016/j.cell.2013.10.034. - DOI - PMC - PubMed
    1. Freer G, Maggi F, Pifferi M, Di Cicco ME, Peroni DG, Pistello M. The virome and its major component, Anellovirus, a convoluted system molding human immune defenses and possibly affecting the development of asthma and respiratory diseases in childhood. Front Microbiol. 2018;9:686. doi: 10.3389/fmicb.2018.00686. - DOI - PMC - PubMed

LinkOut - more resources